Test Code NF4FS Neurofascin-155 IgG4, Flow Cytometry, Serum
Specimen Required
Only orderable as part of a profile. For more information see:
-CIDP / Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Evaluation, Serum
-DMNES / Peripheral Nervous System Demyelinating Neuropathy, Autoimmune Evaluation, Serum
Useful For
Evaluating patients with an underlying demyelinating neuropathy
Diagnosis of a neurofascin-155 IgG4 mediated neuropathy
Method Name
Only orderable as part of a profile. For more information see:
-CIDP / Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Evaluation, Serum
-DMNES / Peripheral Nervous System Demyelinating Neuropathy, Autoimmune Evaluation, Serum
Flow Cytometry (FCM)
Reporting Name
Neurofascin-155 IgG4, SSpecimen Type
SerumSpecimen Minimum Volume
See Specimen Required
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Reference Values
Only orderable as part of a profile. For more information see:
-CIDP / Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Evaluation, Serum
-DMNES / Peripheral Nervous System Demyelinating Neuropathy, Autoimmune Evaluation, Serum
Negative
Interpretation
A positive result is consistent with a neurofascin-155 IgG4 mediated demyelinating neuropathy.
Clinical Reference
1. Ogata H, Yamasaki R, Hiwatashi A, et al. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol. 2015;2(10):960-971
2. Cortese A, Lombardi R, Briani C, et al. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm. 2020;7(1):e639
3. Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 2014;82(10):879-886
Day(s) Performed
Monday, Friday
Report Available
5 to 8 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
86255
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
NF4FS | Neurofascin-155 IgG4, S | 100845-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
614591 | Neurofascin-155 IgG4, S | 100845-7 |